Martin Schroeder

GTB-3550 TriKE™ for the Treatment of High-Risk Myelodysplastic Syndromes (MDS) and Refractory/Relapsed Acute Myeloid Leukemia (AML) Safely Drives Natural Killer (NK) Cell Proliferation At Initial Dose Cohorts

Erica D. Warlick, Daniel J. Weisdorf, Daniel A. Vallera et al. · Blood · 2020 · 40 citations

Medicine, Oncology, Pharmacotherapy +16

444 GTB-3550 tri-specific killer engager TriKE™ drives NK cells expansion and cytotoxicity in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) patients

Martin Felices, Erica D. Warlick, Mark Juckett et al. · Regular and Young Investigator Award Abstracts · 2021 · 20 citations · Full text

Medicine, Immunology, Oncology +17

Safety and efficacy of outpatient treatment with CPT-11 plus bolus folinic acid/5-fluorouracil as first-line chemotherapy for metastatic colorectal cancer

Markus Moehler, Tanja Hoffmann, C. Zanke et al. · Anti-Cancer Drugs · 2003 · 16 citations

Medicine, Oncology, Pharmacology +14

Anatomical Suitability of the Zenith Off-the-Shelf (p-Branch) Endograft in Juxtarenal Aortic Aneurysms Previously Treated Using the Chimney Technique

Martin Schroeder, Konstantinos P. Donas, Konstantinos Stavroulakis et al. · Journal of Endovascular Therapy · 2017 · 12 citations

Medicine, Radiology, Surgery +17